Home > Products > CD3 & PSMA
> Recombinant Anti-CD3 x Anti-PSMA Bispecific Antibody (VHH-Fc-VHH)
Recombinant Anti-CD3 x Anti-PSMA Bispecific Antibody (VHH-Fc-VHH) (CAT#: HCAB-032)
Recombinant Anti-CD3 x Anti-PSMA Bispecific Antibody (VHH-Fc-VHH, Tetravalent HCAb) is a fusion protein of two diabodies connected together by an Fc region. In a diabody, the two VHHs with short linkers are from anti-CD3 and anti-PSMA antibodies. The VH and VL domains form an inter-chain pairing. The diabody with different specificities is fused to the Fc fragment, which results in 2+2 antigen-binding valency and exerts Fc-mediated functions or just extends the half-life. This BsAb can retarget T cells to tumor cells. It is designed for the research of Prostate cancer therapy.
FCGR2B; Fc fragment of IgG, low affinity IIb, receptor (CD32); FcγRIIB; CD32; FCG2; CD32B; FCGR2; IGFR2; low affinity immunoglobulin gamma Fc region receptor II-b; CDw32; fcRII-b; Fc gamma RIIb; fc-gamma-RIIb; fc-gamma RII-b; igG Fc receptor II-b; Fc fragment of IgG, low affinity II, receptor for (CD32); Fc fragment of IgG, low affinity IIb, receptor for (CD32)
There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-PSMA Bispecific Antibody (VHH-Fc-VHH) (HCAB-032). Click the button below to contact us or submit your feedback about this product.